Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ELGAN (22-28SA)”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Not applicableNot Yet RecruitingNCT06737965
What this trial is testing

Cardiovascular Immaturity in Extremely Low Gestational Age Newborns: a Fundamental Prospective Study

Who this might be right for
ELGAN (22-28SA)Extremely Low Gestational Age NewbornsCardiovascular Immaturity
University Hospital, Montpellier 15
Not applicableNot Yet RecruitingNCT07273643
What this trial is testing

Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and Mortality

Who this might be right for
Intraventricular HemorrhagePulmonary HemorrhageDeath+5 more
University Hospital, Montpellier 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07058025
What this trial is testing

Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants

Who this might be right for
Bronchopulmonary Dysplasia (BPD)ELGAN (22-28SA)
Ottawa Hospital Research Institute 168